|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004083,
umls-concept:C0021149,
umls-concept:C0021641,
umls-concept:C0030705,
umls-concept:C0038766,
umls-concept:C0042769,
umls-concept:C0087111,
umls-concept:C0205217,
umls-concept:C0205228,
umls-concept:C0220847,
umls-concept:C2239176
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-5-11
|
|
pubmed:abstractText |
Diabetes mellitus is frequently seen in hepatitis C patients and is often treated with antidiabetic agents that increase serum insulin levels. Because insulin is a growth-promoting hormone, antidiabetic agents could pose a risk for hepatocellular carcinoma (HCC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1478-3231
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
479-86
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:20040053-Carcinoma, Hepatocellular,
pubmed-meshheading:20040053-Case-Control Studies,
pubmed-meshheading:20040053-Diabetes Mellitus, Type 2,
pubmed-meshheading:20040053-Hepatitis C,
pubmed-meshheading:20040053-Humans,
pubmed-meshheading:20040053-Hypoglycemic Agents,
pubmed-meshheading:20040053-Insulin,
pubmed-meshheading:20040053-Liver Cirrhosis,
pubmed-meshheading:20040053-Liver Neoplasms,
pubmed-meshheading:20040053-Male,
pubmed-meshheading:20040053-Risk Factors,
pubmed-meshheading:20040053-Sulfonylurea Compounds
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection.
|
|
pubmed:affiliation |
Department of Digestive Disease Information & Research, Division of Gastroenterology, Kurume University School of Medicine, Kurume, Japan. takumi@med.kurume-u.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
